Cite
Immune modulation via T regulatory cell enhancement: Disease‐modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO).
MLA
Roth, Walter, Franziska, et al. “Immune Modulation via T Regulatory Cell Enhancement: Disease‐modifying Therapies for Autoimmunity and Their Potential for Chronic Allergic and Inflammatory Diseases—An EAACI Position Paper of the Task Force on Immunopharmacology (TIPCO).” Allergy, vol. 76, no. 1, Jan. 2021, pp. 90–113. EBSCOhost, https://doi.org/10.1111/all.14478.
APA
Roth, W. F., Adcock, I. M., Benito, V. C., Bianchini, R., Bjermer, L., Boyman, O., Caramori, G., Cari, L., Fan Chung, K., Diamant, Z., Eguiluz, G. I., Knol, E. F., Kolios, A., Levi, S. F., Nocentini, G., Palomares, O., Redegeld, F., Van Esch, B., & Stellato, C. (2021). Immune modulation via T regulatory cell enhancement: Disease‐modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO). Allergy, 76(1), 90–113. https://doi.org/10.1111/all.14478
Chicago
Roth, Walter, Franziska, Ian M. Adcock, Villalvilla, Cristina Benito, Rodolfo Bianchini, Leif Bjermer, Onur Boyman, Gaetano Caramori, et al. 2021. “Immune Modulation via T Regulatory Cell Enhancement: Disease‐modifying Therapies for Autoimmunity and Their Potential for Chronic Allergic and Inflammatory Diseases—An EAACI Position Paper of the Task Force on Immunopharmacology (TIPCO).” Allergy 76 (1): 90–113. doi:10.1111/all.14478.